Background Image
Table of Contents Table of Contents
Previous Page  99 / 113 Next Page
Information
Show Menu
Previous Page 99 / 113 Next Page
Page Background

99

[170] W. R. Johnson, D. Fedor, and S. Singhal, “Systematic review of surgical treatment techniques for

adult and pediatric patients with pectus excavatum,”

J. Cardiothorac. Surg.

, vol. 9, no. 1, p. 25, 2014.

[171] M. H. Cnossen, K. G. Moons, M. P. Garssen, N. M. Pasmans, A. de Goede-Bolder, M. F. Niermeijer,

and D. E. Grobbee, “Minor disease features in neurofibromatosis type 1 (NF1) and their possible value in

diagnosis of NF1 in children < or = 6 years and clinically suspected of having NF1. Neurofibromatosis

team of Sophia Children’s Hospital,”

J. Med. Genet.

, vol. 35, no. 8, pp. 624–627, Aug. 1998.

[172] D. Richardson and J. K. Thiruchelvam, “Craniofacial surgery for orbital malformations,”

Eye Lond.

Engl.

, vol. 20, no. 10, pp. 1224–1227, Oct. 2006.

[173] R. G. Steen, J. S. Taylor, J. W. Langston, J. O. Glass, V. R. Brewer, W. E. Reddick, R. Mages, and E. K.

Pivnick, “Prospective Evaluation of the Brain in Asymptomatic Children with Neurofibromatosis Type 1:

Relationship of Macrocephaly to T1 Relaxation Changes and Structural Brain Abnormalities,”

Am. J.

Neuroradiol.

, vol. 22, no. 5, pp. 810–817, May 2001.

[174] R. Virdis, M. E. Street, M. A. Bandello, C. Tripodi, A. Donadio, A. R. Villani, L. Cagozzi, L. Garavelli, and

S. Bernasconi, “Growth and pubertal disorders in neurofibromatosis type 1,”

J Pediatr Endocrinol Metab

,

vol. 16 Suppl 2, pp. 289–92, 2003.

[175] F. K. Mensah, J. K. Bayer, M. Wake, J. B. Carlin, N. B. Allen, and G. C. Patton, “Early puberty and

childhood social and behavioral adjustment,”

J. Adolesc. Health Off. Publ. Soc. Adolesc. Med.

, vol. 53, no.

1, pp. 118–124, Jul. 2013.

[176] J. Josefson, R. Listernick, J. R. Fangusaro, J. Charrow, and R. Habiby, “Growth hormone excess in

children with neurofibromatosis type 1-associated and sporadic optic pathway tumors,”

J. Pediatr.

, vol.

158, no. 3, pp. 433–436, Mar. 2011.

[177] B. Kaas, T. A. G. M. Huisman, A. Tekes, A. Bergner, J. O. Blakeley, and L. C. Jordan, “Spectrum and

prevalence of vasculopathy in pediatric neurofibromatosis type 1,”

J. Child Neurol.

, vol. 28, no. 5, pp.

561–569, May 2013.

[178] P. S. Ghosh, A. D. Rothner, T. M. Emch, N. R. Friedman, and M. Moodley, “Cerebral vasculopathy in

children with neurofibromatosis type 1,”

J. Child Neurol.

, vol. 28, no. 1, pp. 95–101, Jan. 2013.

[179] A. G. Cairns and K. N. North, “Cerebrovascular dysplasia in neurofibromatosis type 1,”

J. Neurol.

Neurosurg. Psychiatry

, vol. 79, no. 10, pp. 1165–1170, Oct. 2008.

[180] Nederlandsche Internisten Vereeniging, “Richtlijn Hypertensieve crisis,” 2010.

[181] A. E. Lin, P. H. Birch, B. R. Korf, R. Tenconi, M. Niimura, M. Poyhonen, K. Armfield Uhas, M. Sigorini, R.

Virdis, C. Romano, E. Bonioli, P. Wolkenstein, E. K. Pivnick, M. Lawrence, and J. M. Friedman,

“Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1,”

Am. J.

Med. Genet.

, vol. 95, no. 2, pp. 108–117, Nov. 2000.

[182] M. Venturin, P. Guarnieri, F. Natacci, M. Stabile, R. Tenconi, M. Clementi, C. Hernandez, P.

Thompson, M. Upadhyaya, L. Larizza, and P. Riva, “Mental retardation and cardiovascular malformations

in NF1 microdeleted patients point to candidate genes in 17q11.2,”

J. Med. Genet.

, vol. 41, no. 1, pp. 35–

41, Jan. 2004.

[183] R. S. Darken, R. Bogitch, J. Leonard, A. Perry, R. C. McKinstry, D. H. Gutmann, and J. B. Rubin,

“Brainstem glioma presenting as pruritus in children with neurofibromatosis-1,”

J. Pediatr. Hematol.

Oncol.

, vol. 31, no. 12, pp. 972–976, Dec. 2009.

[184] K. Khosrotehrani, S. Bastuji-Garin, V. M. Riccardi, P. Birch, J. M. Friedman, and P. Wolkenstein,

“Subcutaneous neurofibromas are associated with mortality in neurofibromatosis 1: a cohort study of

703 patients,”

Am. J. Med. Genet. A.

, vol. 132A, no. 1, pp. 49–53, Jan. 2005.

[185] Y. Kuraishi, “Potential new therapeutic targets for pathological pruritus,”

Biol. Pharm. Bull.

, vol. 36,

no. 8, pp. 1228–1234, 2013.

[186] D. E. O’Brien, D. S. Brenner, D. H. Gutmann, and R. W. Gereau, “Assessment of pain and itch behavior

in a mouse model of neurofibromatosis type 1,”

J. Pain Off. J. Am. Pain Soc.

, vol. 14, no. 6, pp. 628–637,

Jun. 2013.